Online citations, reference lists, and bibliographies.
← Back to Search

Association Of Stress With Symptoms Of Atopic Dermatitis.

S. Oh, B. Bae, C. Park, J. Noh, I. Park, W. H. Wu, K. Lee
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Psychological stress and atopic dermatitis (AD) symptoms appear to form a vicious cycle. This study compared the degree of stress and impairment of dermatology life quality between patients with AD and healthy controls, and examined for neuropeptides and neurotrophins associated with stress in AD. Questionnaires, comprising five tests evaluating depression, anxiety, interaction anxiousness, private body consciousness, and dermatology life quality, were examined in age- and sex-matched patients with AD (n = 28) and healthy controls (n = 28). Immunohistochemical staining of nerve growth factor, substance P, corticotrophin-releasing factor receptor and neuropeptide Y was performed in the AD-involved and normal skin. Patients with AD showed high scores on all of the questionnaires, including Beck Depression Inventory, state anxiety, trait anxiety, Interaction Anxiousness Scale, Private Body Consciousness subscale, and Dermatology Life Quality Index. All of the parameters, except for Beck Depression Inventory, showed higher values in AD than healthy controls (p < 0.001). Statistically significant correlations were observed between each psychological parameter and Dermatology Life Quality Index. Among the clinical parameters, only pruritus was positively correlated with state anxiety (R = 0.573, p < 0.05) and trait anxiety (R = 0.525, p < 0.05). The Eczema Area and Severity Index score did not show any significant correlations with psychological parameters. Nerve growth factor-reactive cells were observed more abundantly and intensely in both epidermis and dermis of AD involved skin (n = 4) than in healthy controls (n = 3) (p = 0.022 and 0.029, respectively). Also, the number and intensity of neuropeptide Y-positive cells was significantly greater in the entire epidermis of patients with AD than in healthy controls (n = 3) (p = 0.029 and 0.026, respectively). We conclude that anxiety may be associated with the induction of pruritus through neuro-peptide Y and nerve growth factor.
This paper references
10.1001/ARCHPSYC.1961.01710120031004
An inventory for measuring depression.
A. Beck (1961)
Diagnostic features of atopic dermatitis
J. Hanifin (1980)
[Atopic dermatitis].
I. Lelis (1980)
Diagnostic features of atopic dermatitis . 10
J Hanifin (1980)
10.1037/0022-3514.41.2.397
Consciousness of Body: Private and Public
L. Miller (1981)
A Standardization study of Beck Depression Inventory in Korea
H. Hahn (1982)
Physiological Roles of Nerve Growth Factor in Adult Rodents: A Biobehavioral Perspective
E. Alleva (1989)
rodents: a biobehavioral perspective
E Alleva (1989)
10.1016/0166-4328(90)90120-4
Changes of NGF level in mouse hypothalamus following intermale aggressive behaviour: Biological and immunohistochemical evidence
L. Aloe (1990)
10.1111/j.1365-2133.1990.tb06261.x
Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study
C. Pincelli (1990)
Changes of NGF level
L Aloe (1990)
Social 29 . status and nerve growth factor serum levels after agonistic encounters inmice
D Maestripieri (1990)
Immunopharmacologic aspects of atopic dermatitis.
C. Sc (1993)
10.1207/S15327752JPA6101_10
The Interaction Anxiousness Scale: construct and criterion-related validity.
M. Leary (1993)
10.1111/j.1365-4362.1993.tb04021.x
ROLE OF EMOTIONAL FACTORS IN ADULTS WITH ATOPIC DERMATITIS
I. H. Ginsburg (1993)
Immunopharmacologic aspects of 8 . atopic dermatitis
SC Chan (1993)
10.1073/PNAS.91.22.10440
Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes.
L. Aloe (1994)
10.1111/j.1365-2230.1994.tb01167.x
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use
A.Y. FINLAY (1994)
10.4135/9781483365817.n1316
State-Trait Anxiety Inventoryによるペインクリニック外来患者の不安の評価
福田 博一 (1994)
10.1016/S0140-6736(95)92089-7
Epidermal mast cells in atopic dermatitis
S. Imayama (1995)
10.1111/j.1365-2826.1995.tb00757.x
Neuropeptide Y (NPY) May Integrate Responses of Hypothalamic Feeding Systems and the Hypothalamo‐Pituitary‐Adrenal Axis
E. Simon Hanson (1995)
10.1037//0022-006X.63.4.624
Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention.
A. Ehlers (1995)
10.1037/0022-006x.63.4.624
Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention.
A. Ehlers (1995)
Neuropeptide Y ( NPY ) may 44 . integrate responses of hypothalamic feeding systems and the hypothalamo - pituitary - adrenal axis
ES Hanson (1995)
10.1016/0091-3057(95)02111-6
NGF regulatory role in stress and coping of rodents and humans
E. Alleva (1996)
10.1016/S0166-2236(96)10058-8
Nerve growth factor: from neurotrophin to neurokine
R. Levi‐Montalcini (1996)
Korean adaptation of Spielberger's STAI (K-STAI)
Dw Hahn (1996)
NGF regulatory 32 . role in stress and coping of rodents and humans
E Alleva (1996)
The Interaction Anxiousness
MR Leary (1996)
10.1016/S0926-9959(98)94829-2
Vasoactive peptides in the skin.
J. Wallengren (1997)
10.1016/S0923-1811(96)00553-1
Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity.
M. Hashiro (1997)
10.1016/S0091-6749(98)70135-6
Nerve growth factor is preformed in and activates human peripheral blood eosinophils.
A. Solomon (1998)
10.1046/j.1365-2133.1999.02696.x
Emotional dysfunction, child–family relationships and childhood atopic dermatitis
Howlett (1999)
10.1046/j.1365-2133.1999.02661.x
An assessment of anxiety and dermatology life quality in patients with atopic dermatitis
Linnet (1999)
10.1002/(SICI)1097-4547(19990315)55:6<749::AID-JNR9>3.0.CO;2-N
Microsphere embolism‐induced elevation of nerve growth factor level and appearance of nerve growth factor immunoreactivity in activated T‐lymphocytes in the rat brain
Hideyuki Mizuma (1999)
childhood atopic dermatitis
J Linnet (1999)
10.1016/S0006-8993(00)02285-X
Behavioral characterization of neuropeptide Y knockout mice
A. Bannon (2000)
10.1016/S0006-3223(99)00185-7
Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD
A. Rasmusson (2000)
10.1159/000049674
Stress and Atopic Dermatitis
V. Benea (2001)
10.1159/000056219
Psychobiological Aspects of Atopic Dermatitis: An Overview
A. Buske-Kirschbaum (2001)
10.1046/j.1365-4362.2001.01272.x
Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients
J. Linnet (2001)
dition predicts outcome of psychotherapy in atopic dermatitis patients
D Staab (2001)
10.1046/j.1365-2133.2002.04803.x
Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis
M. Toyoda (2002)
10.1001/ARCHDERM.139.11.1479
Modern aspects of cutaneous neurogenic inflammation.
M. Steinhoff (2003)
10.1046/j.1468-3083.2003.00618.x
Psyche and skin: What's new?
U. Gieler (2003)
skin: what’s new
R Paus (2003)
Psyche and 24 . skin : what ’ s new ?
U Gieler (2003)
10.1016/S0002-9440(10)63294-4
Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor.
E. Peters (2004)
10.1111/j.1346-8138.2005.tb00738.x
Psychosomatic Analysis of Atopic Dermatitis Using a Psychological Test
M. Arima (2005)
10.1111/j.1398-9995.2004.00628.x
Mast cells and vasculature in atopic dermatitis – potential stimulus of neoangiogenesis
D. Groneberg (2005)
10.3109/9780203091449-7
[Pathogenesis of atopic dermatitis].
J. Nicolas (2005)
10.1111/j.1365-2133.2005.06449.x
Anxiety accelerates T‐helper 2‐tilted immune responses in patients with atopic dermatitis
H. Hashizume (2005)
10.1016/j.bbi.2004.08.005
Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin
E. Peters (2005)
10.1007/s00403-006-0657-1
Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study
Ying-Chun Dou (2006)
10.1016/J.IT.2005.10.002
Neuroimmunoendocrine circuitry of the 'brain-skin connection'.
R. Paus (2006)
10.1159/000104863
From the Brain-Skin Connection: The Neuroendocrine-Immune Misalliance of Stress and Itch
P. Arck (2006)
10.1136/bmj.332.7547.933
Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial
D. Staab (2006)
10.1097/01.all.0000244793.03239.40
Anxiety in allergy and atopic dermatitis
H. Hashizume (2006)
10.1172/JCI28553
Frontiers in pruritus research: scratching the brain for more effective itch therapy.
R. Paus (2006)
brain-skin connection
D Maestripieri (2006)
10.1007/s00213-007-0945-2
The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice
Rose-Marie Karlsson (2007)
10.1111/j.1468-3083.2007.02399.x
The role of selected neuropeptides in pathogenesis of atopic dermatitis
J. Salomon (2008)
Stress and atopic dermatitis . Curr 6
J Arndt (2008)
10.1007/978-0-387-78665-0_5473
Dermatology Life Quality Index
V. Preedy (2010)
Atopic dermatitis: an overview.
R. Berke (2012)



This paper is referenced by
10.1111/jdv.17278
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial
A. Wollenberg (2021)
10.25100/RE.V28I2.10829
La descodificación biológica y las alteraciones craneofaciales, una mirada desde las ciencias básicas
Nayely Del Pilar Chilanguad (2021)
10.1007/978-3-030-54307-5_10
Eczema and Psychodermatology
Alia Ahmed (2021)
10.1007/s00403-021-02246-7
Quality of life in atopic dermatitis in Asian countries: a systematic review
Jinghui Huang (2021)
Atopic dermatitis – intensification of skin ailments in autumn and winter
(2021)
10.1111/ddg.14328
Skin and Psychosomatics – Psychodermatology today
U. Gieler (2020)
10.1111/jdv.16950
Social and psychosocial effects on atopic eczema symptom severity – a scoping review of observational studies published from 1989 to 2019
K. Harter (2020)
10.1007/s00403-020-02074-1
The utility of PROMIS domain measures in dermatologic care
F. Esaa (2020)
10.17116/klinderma202019031297
Atopic dermatitis and the role of zinc in maintaining skin barrier properties
E. Matushevskaya (2020)
Sexually Transmitted Diseases Frontiers in Dermatology and Venereology-A series of theme issues in relation to the 100-year anniversary of ActaDV
E. Fowler (2020)
Selected therapeutic methods affecting the health and quality of life of chronically dermatologically ill people
A. Ścisłowska-Czarnecka (2020)
10.17116/jnevro2020120051131
[Stress-induced disorders].
R. Esin (2020)
Centenary theme section : ITCH AND PRURITIC DISORDERS
R. Reszke (2020)
10.14744/TurkPediatriArs.2020.63549
Assessment of dermatological quality of life in patients with childhood atopic dermatitis and their families
F. Çömlek (2020)
10.1080/09546634.2020.1782321
Multidisciplinary Management of Chronic Atopic Dermatitis in Children and Adolescents: A Prospective Pilot Study.
K. Leong (2020)
10.1016/j.clinthera.2020.01.025
Effects of Stress on Itch.
R. S. Golpanian (2020)
10.1016/j.anai.2020.03.023
Association of atopic dermatitis with suicide risk among 788,411 adolescents: A Korean cross-sectional study.
Yechan Kyung (2020)
10.1111/ddg.14328_g
Haut und Psychosomatik – Psychodermatologie heute
U. Gieler (2020)
10.1007/s13555-020-00365-z
Patient Education Programs in Pediatric Atopic Dermatitis: A Systematic Review of Randomized Controlled Trials and Meta-Analysis
Mutong Zhao (2020)
10.1111/1346-8138.15386
Health‐related behaviors and mental health states of South Korean adolescents with atopic dermatitis
Yechan Kyung (2020)
10.1111/exd.13941
Why does stress aggravate itch? A possible role of the amygdala
D. Pavlenko (2019)
10.1080/13548506.2019.1710545
Determination of depression, anxiety and stress (DAS) levels in patients with atopic dermatitis: a case-control study
Songül Duran (2019)
Quality of life in patients with atopic dermatitis.
Kamilla Koszorú (2019)
10.1097/DER.0000000000000418
Atopic Dermatitis and Hospitalization for Mental Health Disorders in the United States
D. Hsu (2019)
10.1007/978-981-10-5541-6_17
Clinical Manifestation: Adult-Type Atopic Dermatitis
A. Takahashi (2018)
10.2340/00015555-2797
Psychological Health Status and Health-related Quality of Life in Adults with Atopic Dermatitis: A Nationwide Cross-sectional Study in South Korea.
S. H. Lee (2018)
10.1016/j.neubiorev.2018.01.009
The vicious cycle of itch and anxiety
K. M. Sanders (2018)
10.2340/00015555-2852
Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis.
L. Lönndahl (2018)
10.1016/j.jaad.2018.03.017
Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta‐analysis
Amalie Thorsti M&phgr;ller R&phgr;nnstad (2018)
10.1007/978-3-319-46352-0_6
Itch and Stress
J. Szepietowski (2017)
10.1055/S-0037-1608914
Die Assoziation von Allergien und psychischen Auffälligkeiten im Kindes- und Jugendalter
W. Keller (2017)
10.1007/s13671-017-0168-7
Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
Y. Andersen (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar